# The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM

> **NCT02844309** · PHASE4 · COMPLETED · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 44 (actual)

## Conditions studied

- Waldenström Macroglobulinemia

## Interventions

- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT02844309
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-11
- **Final completion:** 2020-05
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02844309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02844309, "The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02844309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*